Stanley Druckenmiller's position in Verona Pharma Plc is currently worth $107M. That's 2.51% of their equity portfolio (13th largest holding). The investor owns 1.18% of the outstanding Verona Pharma Plc stock. The stake costed the investor $31.3M, netting the investor a gain of 242% so far.